FIELD: medicine.
SUBSTANCE: invention refers to medicine and is applicable for fistula sanitation in infected pancreonecrosis. The agent represents an aqueous acidic buffer hyperosmotic solution containing 0.9% sodium chloride, 0.142 % sodium hydrophosphate and 0.120% sodium dihydrophosphate.
EFFECT: invention provides the intrafistular and intravitous destruction of pathogenic microflora, elimination of alkaline activity and reduction of enzymatic activity of pancreatin, providing reduced macerate and corrosive action of exudate.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AERATED MOUTHWASH | 2016 |
|
RU2635992C1 |
| HYPER-GASSED AND HYPER-OSMOTIC ANTISEPTIC MIXTURE | 2006 |
|
RU2331441C1 |
| MULTIPURPOSE SOLUTION FOR EPIBULBAR INSTILLATIONS | 2011 |
|
RU2452478C1 |
| METHOD FOR STOMACH LAVAGE | 2014 |
|
RU2551305C1 |
| METHOD FOR INTEROPERATIONAL ULTRASONIC ESTIMATION OF STATE AND VIABILITY OF THE PANCREAS AT PANCREATITIS | 2003 |
|
RU2257851C2 |
| AEROSOL FOR INVASIVE MECHANICAL VENTILATION IN COVID-19 | 2020 |
|
RU2742505C1 |
| AGENT FOR INCREASING RESISTANCE TO HYPOXIA | 2015 |
|
RU2604129C2 |
| CREAM-MILK FOR ZOSTER TREATMENT | 2016 |
|
RU2634264C1 |
| METHOD FOR SANITIZING PURULENT-NECROTIC FOCI OF ABDOMINAL CAVITY AND RETROPERITONEAL SPACE AT ACUTE DESTRUCTIVE PANCREATITIS | 2005 |
|
RU2311873C2 |
| METHOD OF PREVENTING INTESTINAL FISTULAS IN STAGED TREATMENT OF PANCREATONECROSIS | 2011 |
|
RU2463003C1 |
